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This paper analyses the socio-economic impact of providing antiretroviral 
therapy to AIDS-patients in Khayelitsha, Cape Town. The analysis employs data 
from a 2002 panel study of AIDS-patients receiving ARV treatment. This sample 
is placed within a comparative context by reporting comparable data from a 
2000/1 survey of Khayelitsha. The comparative analysis shows that ARV 
patients suffered higher rates of ill health and experienced lower labour force 
participation rates than the Khayelitsha sample. Findings from the 2002 panel 
survey indicate that, after one year of treatment, the health status and labour 






In May 2001, the Western Cape Provincial Government in collaboration with 
Medecins Sans Frontieres (MSF) launched a pilot programme to provide highly 
active antiretroviral (ARV) therapy for AIDS-patients in Khayelitsha.  
Khayelitsha is Cape Town’s largest African township and is home to many 
unemployed and poor people (Nattrass, 2002).  It is thus a test case for exploring 
the challenges of offering an AIDS treatment programme in a poor urban 
community and assessing the impact of treatment on the socio-economic status 
of ARV patients.   
 
In January 2002, researchers from MSF and the University of Cape Town 
conducted a socio-economic panel study of people who had just started ARV 
therapy.1  In the ‘base-line’ interview, each person was asked questions about 
who they had disclosed their HIV status to, and about their basic socio-
                                                 
1 We would like to acknowledge the following people who were involved in the design and 
implementation of the surveys used in this paper:  The ARV Survey (Marta Darda, Toby Kaspar, Eric 
Goemere, Emi MacLean); and the Khayelitsha Mitchell’s Plain Survey (Murray Leibbrandt, Nicoli 
Nattrass, Dudley Horner, Jeremy Seekings, Owen Crankshaw, Francis Wilson and Kermit Anderson).  
Marta Darda and EmiLou MacLean designed the MSF survey and managed the data collection. 
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economic characteristics such as labour-market status and income.  One hundred 
and thirty seven base-line interviews were collected in 2002.2  Respondents were 
re-interviewed on a six-monthly basis in order to explore the socio-economic 
impact of providing ARVs.  The working hypothesis of the study was that 
restoring an individual’s health is likely to reduce the burden of care on the 
household, reduce health-care expenditure and increase the number of hours the 
individual could be productively employed or search for work.      
 
This paper paints a socio-economic picture of Khayelitsha residents who started 
ARV treatment in 2002.  In order to locate these respondents within an 
appropriate broader context, comparative data is presented from a representative 
sample of Khayelitsha residents who were interviewed as part of the 
Khayelitsha/Mitchells Plain survey of 2000/1.  This enables us to see how the 
socio-economic situation of people living with AIDS compares to that of the 
broader population of Khayelitsha residents.  The paper also describes the key 
changes that have taken place over time for those 104 ARV patients who 
remained in the sample after one year of treatment.     
 
 
1.1 Selection into the Programme 
 
When the ARV pilot project was designed, selection into the programme was to 
be determined according to a set of clinical, behavioural and socio-economic 
criteria (MSF et al, 2003).  Patients had to meet all the selection criteria in order 
to be included.  As outlined in MSF (2003), these were as follows:  
 
1. Clinical Criteria 
• World Health Organisation classification of being in Stages 3 or 4, or 
asymptomatic patients with CD4+T cell counts of less than 50/mm3. 
• Karnofsky Performance Score greater than 40% 
 
2.  Biological Criteria 
• Two tests confirming HIV serostatus (either ELISA or Rapid tests); 
• CD4+T cell counts from 0 to 200/mm; 
 
3.  Ability to adhere to therapy 
• Attended the clinic for at least three months; 
• Arrived on time for the previous four visits; 
• Able to take medication regularly. 
 
 
                                                 
2 See Coetzee (2003) for the initial ‘base-line’ report. 
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4. Social Criteria 
• A fixed address in (greater) Khayelitsha for more than three months; 
• Stable home environment and treatment support structure; 
• Not on a medical aid scheme which provides ARVs; 
• Commitment to attend a support group regularly; 
• Open about HIV status and ready to commit to long-term ARV treatment; 
• Priority to be given to patients who have dependents or who are very 
poor. 
 
Criteria 3 and 4 introduced a set of behavioural and social criteria which were 
likely to result in the sample of ARV patients manifesting a degree of selection 
bias.  In other words, the sample of ARV patients is unlikely to be a random 
selection of potential ARV patients.  This is because the social and behavioural 
criteria select against richer people, against those who do not wish to disclose 
their HIV status, and against those judged to be living without an adequate 
support infrastructure.  However, according to those managing the programme, 
no one who manifests the requisite clinical signs has been denied treatment.  
This is in part because the disclosure criterion was judged to have been fulfilled 
if the patient had disclosed to one other person (who was to act as a treatment 
assistant). It was also in part the result of counselling received from the clinic to 
help those who initially did not comply (for example not arriving on time for 
appointments).  No person was turned away because they were judged to be too 
well off.  
 
This suggests that the sample of ARV patients can probably be judged to be a 
fairly representative sample of people with AIDS presenting themselves to 
clinics for treatment.  Note that this does not mean that the sample of ARV 
patients can be regarded as a representative sample of people with AIDS in the 
area.  This is because not all people with AIDS present themselves to clinics for 
treatment.  Many may never know their HIV status and die unassisted, while 
others may choose instead to seek out alternative therapies (e.g. visit traditional 
healers) instead of visiting the clinic.  Pregnancy seems to be one of the key 
determinants of a person participating in a voluntary counselling and testing 
programme – which is why treatment programmes are overwhelmingly 
dominated by young women.  Thus, to the extent that the sample of people who 
know their HIV status is not a random selection of the general population of 
HIV-positive people, the sample of those on treatment thus manifests a degree 
of selection bias.  However, this is not a function of the selection criteria (as 
these appear to have had no impact in terms of turning potential patients away), 





1.2 Disclosure of HIV Status 
 
Given that disclosure of HIV status was one of the criteria for selection into the 
ARV programme, it is worth exploring the nature of that disclosure.  As can be 
seen from Table 1, 82.5% reported that they had disclosed to one or more family 
member, and of the two-thirds of the sample who reported having a (sexual) 
partner, 85.1% reported having disclosed to him or her.  However, it is worrying 
to note that significantly fewer individuals disclosed to more than one family 
member than those who disclosed to at least one family member.  Only about a 
third of respondents (35.6%) reported having disclosed to at least one friend and 
at least one family member.  There is thus a significant group of respondents 
who disclosed to only one person at the start of their ARV treatment.  This is a 
very low level of disclosure – and it is possible that the only reason why they 
disclosed was to get access to the ARV treatment.  
 
 








% of sample 
failing to 
answer 
Disclosed to their support group 98 72.6% 1.5% 
Disclosed to one or more friend 47 34.8% 1.5% 
Disclosed to one or more family member 113 82.5% 1.5% 
Disclosed to one or more friend and one or 
more family members 
48 35.6% 1.5% 
Disclosed to partner only 18 21.7% 1.5% 
    
Disclosed to more than one friend 36 27.7% 2.9% 
Disclosed to more than one family member 73 57.9% 8.0% 
Disclosed to more than one friend and more 
than one family member 
23 18.7% 10.2% 
    
Disclosed to their partner* 80 85.1% 3.7% 
Disclosed to their partner if they also disclosed 
to more than one friend* 
23 100% 4.2% 
Disclosed to their partner if they did not 
disclose to more than one friend* 
53 79.1% 1.5% 
Disclosed to their partner if they also disclosed 
to more than one family member* 
37 78.7% 6.0% 
    
Disclosed to spiritual leader 22 16.5% 2.9% 
Disclosed to current or former employer 13 10.2% 7.3% 
Public disclosure 11 8.5% 5.8% 




More respondents reported having disclosed to more than one family member 
than having disclosed to more than one friend.  This suggests that respondents 
find it easier to be more open about the HIV status to family rather than to 
friends.  Perhaps they believe that family members are more likely to be discreet 
than their friends.  To the extent that family members suffer from reflected 
stigma (i.e. stigma that arises from living in the same household or being related 
to someone with AIDS), one might suppose that this assumption about 
discretion is correct.  However, very little is actually known about the nature of 
the stigma and reflected stigma associated with people living with AIDS in 
Khayelitsha.   
 
It is interesting to note that of those who disclosed to more than one friend, 
100% of those with sexual partners disclosed to their partners.  This suggests 
that once an individual has taken the step of disclosing to more than one friend, 
that such disclosure is effectively public – and hence it is impossible not to 
disclose to the sexual partner (as he or she is likely to hear about it ‘through the 
grapevine’.  The same pattern does not hold for those disclosing to one or more 
family member.  Put differently, taking the step to disclose to friends is 
associated with taking a similar step to disclose to a sexual partner – whereas 
this is not the case with regard to disclosure to family.  
 
As noted above, 137 people were included in the baseline study.  Of these, only 
104 answered the second questionnaires a year later.  Most of the missing 
respondents died; there was a 16% death rate (MSF, et al, 2003: 5).  If we 
compare the levels of disclosure in the ARV sample of those who had been on 
treatment for a year, then we can see that disclosure levels increased 
substantially over the period with regard to friends and family members (see 
Table 2).  
 
The story for disclosure to partners, however, is more complex.  As can be seen 
from Table 2, the answer to the question:  “Have you disclosed to your partner?” 
changed significantly over the period.  At the start of the programme, 30% of the 
sample reported that they had no sexual partner.  One year later, only one person 
reported not having a sexual partner.  This is clearly an indicator of restored 
health – and is consistent with two parallel studies of these same ARV patients; 
one measuring clinical improvements (MSF, 2003); and the other probing 
quality of life (Jelsma et al, 2003). 
 
According to the clinical study, the proportion of patients with undetectable 
loads rose to 83% after a year on treatment, and median weight gain was 10.kg 
per patient (MSF, 2003: 5).  These are strong indications of substantially 
improved health status.  The study measuring changes in quality of life (Jelsma 
et al, 2003) found that the ARV patients at base-line (i.e. just as they were about 
 6
to start treatment) had significantly poorer quality of life (measured on a range 
of factors) than was the case for a sample of people from the community.  
However, after 6 months of treatment, the quality of life of ARV patients was 
comparable with that of the community sample.  In other words, both the 
clinical and quality of life studies provide ample evidence of improved health 
for the ARV patients.   
 
 
Table 2:  Changes in Disclosure for the 104 people who Remained Part of the 
Sample 
 
 At the start of the 
programme (base 
line) 
After one year 
of treatment 
Percentage disclosing to more than one 
friend 
32.0% 56.7% 
Percentage disclosing to more than one 
family member 
60.6% 77.9% 
   
Have you disclosed to your partner?   
Yes 53.9% 19.2% 
No 11.5% 79.8% 
I don’t have a partner 29.8% 1% 
Missing answer 4.8% 0% 
Total 100% 100% 
   
The percentage of those with sexual partners 
who disclosed to their sexual partners 
82.4% 80.4% 
 
It is thus not surprising that more ARV patients had sexual partners a year after 
being on treatment than at the start of treatment.  Disclosure rates (for those with 




2.  Socio-Economic Profile 
 
This section of the paper provides a socio-economic profile of the ARV patients.  
A comparative context is provided by the Khayelitsha/Mitchell’s Plain (KMP) 
survey which was conducted in 2000/1.   This random survey interviewed all 
adults over the age of eighteen in each household in Khayelitsha and Mitchell’s 
Plain.  A sample of 2,644 individuals was obtained in the process.  If the sample 
of adults is restricted to African adults below the age of 59 and over the age of 
20 (in order to provide a better point of comparison for the ARV sample, all of 
whom were Africans and below the age of 56), then a ‘restricted’ sample of 
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1,536 African adults is obtained.  This paper presents socio-economic statistics 
for this restricted sample of Africans.  
 
Table 3 summarises basic demographic information in the two studies.  It shows 
that the ARV patients had a far higher proportion of women than was the case 
for the representative sample of Khayelitsha residents.  This is consistent with 
the higher HIV prevalence rates amongst young women compared to men – 
hence we would expect the ARV sample to be more weighted towards females 
than would be the case for the area in general. The average age and school grade 
attained were, however, comparable between the two studies.  The proportion of 
respondents living with a spouse was almost identical between the two samples, 
although relatively fewer female ARV patients lived with a resident spouse than 
was the case for their counterparts in the representative survey of Khayelitsha.  
Average household size was almost identical between the two surveys.  This 
suggests that ARV patients are fairly typical members of the Khayelitsha 
community, except for the fact that they are disproportionately women.  
 
 
Table 3:  Key Demographic Characteristics for ARV Patients and a 
Comparative Sample from Khayelitsha 
 




Average Age 33.8 34.4 
% women 70.1% 57.5% 
% women with a resident spouse 19.8% 28.7% 
% with a resident spouse 29.2% 30.9% 
% of the total sample with a resident genetic child (or 
children) 
54.0% 56.8% 
% women with a resident genetic child (or children) 55.2% 65.8% 
% with a genetic child (or children) living in another 
household* 
6.6% 36.7% 
% of women with a genetic child (or children) living in 
another household* 
4.2% 36.0% 
% of those with no resident genetic children, who have 
genetic children resident elsewhere* 
6.3% 38.0% 
% of women with no resident genetic children, but who 
have genetic children resident elsewhere* 
4.7% 40.7% 
% of those with resident genetic children who also 
have genetic children resident elsewhere* 
6.8% 55.2% 
% of women with resident genetic children who also 
have genetic children resident elsewhere* 
3.8% 61.3% 
Highest school grade passed 9.2 8.5 
Average household size 4.9 4.6 
* The data are not comparable between the two surveys because the ARV survey merely asked if a 
genetic child had “left” the household – rather than asking if there were any genetic children living in 
other households (as was the case in the KMP survey).  
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Significantly more women than men in the KMP samples had resident children 
compared to the ARV patients.  This is perhaps because men who are on 
antiretroviral treatment are more likely to be living with their children than men 
in general.  This may reflect the fact that men are more likely to seek treatment 
when they are in a stable family situation than when they are not.  It may also, 
however, reflect the influence of the programme’s selection criteria.  As noted 
earlier, the ARV programme requires that patients live in a ‘stable home 
environment’ – thus perhaps creating an incentive for HIV-positive men to 
move back in with their families in order to access treatment.   
 
A higher proportion of women in the representative Khayelitsha sample were 
likely to be living with at least one of their children than was the case for the 
ARV patients.  This could reflect the fact that people living with AIDS have 
lower fertility rates than other women.  One could also hypothesise that women 
living with AIDS are more likely to send their children to live in other 
households because they find the burden of child-care too hard.  For example, 
Oni et al (2002) found that some AIDS-affected households in Limpopo sent 
children away from the household as a coping strategy.  But according to the 
comparative data presented in Table 3, very few of the ARV patients indicated 
that a child (or children) had left the household.   The table also suggests that a 
far higher proportion of the representative Khayelitsha sample (both for women 
and for the entire sample) had genetic children living in other households than 
was the case for the ARV patients.  However, the questions asked in the two 
surveys are not actually comparable.  Whereas the Khayelitsha survey asked if 
there were any genetic children living elsewhere, the ARV survey asked if a 
genetic child had ‘left’ the existing household.  One would thus expect the 
Khayelitsha survey to reflect a higher proportion of children living elsewhere.  
 
 
2.1 Unemployment and Labour-Force Participation 
 
Table 4 explores the labour market status of the ARV patients and places them 
in a comparative context by using data from the Khayelitsha survey for Africans 
below 59 and over 20 years of age.  The table indicates that the unemployment 
rates are fairly close between the two surveys.  The searching unemployed 
expressed as a percentage of the labour force (defined as the employed plus the 
searching unemployed)3 is the calculation for the strict unemployment rate. As 
can be seen from the table, the ARV patients had a higher strict unemployment 
rate than was the case for the Khayelitsha sample. However, the case is reversed 
                                                 
3 The Khayelitsha/Mitchells Plain survey allowed for a fine-tuned exploration of different definitions 
of unemployment (Nattrass, 2002).  The unemployment rates used in this paper follow the definitions 
used in the ARV survey (i.e. the definition used in the ARV survey was applied to the Khayelitsha 
sample for the purposes of this analysis).  
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with regard to the broad unemployment rate.  The broad unemployment rate 
includes in the labour force as unemployed those individuals who say they 
would like a job, but who are not actively searching for work.   
 
 
Table 4:  Comparative Labour-Market Information 
 
 ARV patients 
(base line) 
Africans living in 
Khayelitsha 
1. Wage employed 30      (56.6%) 534    (72.1%) 
2. Casual employed 6        (11.3%) 50       (6.7%) 
3. Self employed 17      (32.1%) 157    (21.2%) 
4.   Total Employed (1+2+3) 53       (100%) 741    (100%) 
   
5. Unemployed (strict) 34 367 
6. Unemployed (broad) 44 695 
7. Non labour force participants (strict) 50 397 
8. N 137 1505 
9. Missing values 0 31 
10. Total N (8+9) 137 1536 
   
Unemployment rate (strict) (5/(4+5)) 39.1% 33.1% 
Unemployment rate (broad) 
(6/(4+6)) 
45.4% 48.4% 
Labour force participation rate (strict) 
(4+5)/8 
63.5% 73.6% 




Researchers who prefer using the strict definition (which is the international 
standard) do so on the grounds that only active job-seekers should be counted as 
unemployed, because they (unlike the non-active job seekers) are actually 
‘participating’ in the labour-market.  Those who merely report that they would 
like a job (but are not looking for one) may, according to this view, not really be 
willing and available for work.  Researchers who favour the broad definition, 
argue that non-active work-seekers are often discouraged (by the lack of jobs) 
and are too poor to seek work actively (Kingdon and Knight, 2001).   In this 
view, excluding those not actively seeking work from the labour force is simply 
defining away a real social problem.   
 
The big difference between the ARV patients and the representative Khayelitsha 
sample is – as is to be expected – with regard to labour force participation rates.  
The labour force participation rate is the number of people who are in the 
labour force (i.e. are either defined as employed or unemployed) expressed as a 
percentage of the number of people of working age.  The table shows that the 
(broad) labour force participation rate for the ARV patients was only 70.8% as 
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opposed to 95.4% for the comparative sample of Africans in Khayelitsha.  The 
high non-labour force participation rate of course reflects the fact that the ARV 
patients were very ill at the time of the base-line study – i.e. they had reached 
the clinical stage where they were deemed ready to start ARV treatment.  Many 
of them thus may ideally want to work, but were at the time simply too ill to 
work or look for work.   Of the 40 (broadly defined) non labour force 
participants, 90% said that they were too ill to work. 
 
Table 5 shows that labour-force participation changed significantly for the ARV 
patients over the first year of treatment.  This is clearly a further sign of restored 
health as a result of ARV treatment.  As shown in Table 5, labour-force 
participation increased – manifesting itself in an increase in the number of 
employed and in the number of searching unemployed.  Because more people 
started searching for jobs than were able to find them, the unemployment rate 
actually rose over the period.    
 
 
Table 5:  Changes in Labour Force Participation for the 104 ARV Patients for 
whom we have a Year’s Worth of Data.   
 
 At the start of the 
programme (base line) 
After one year of 
treatment 
Employed 44    (42.3%) 55    (52.9%) 
Searching Unemployed 25    (24.1%) 33    (31.7%) 
Non-labour force Participants 35    (33.7%) 16    (15.4%) 
Total 104  (100%) 104  (100%) 
 Pearson’s Chi2= 9.4041 (pr=.009) 
   
Unemployment rate (strict) 36.2% 37.5% 
Labour force participation rate (strict) 66.4% 84.6% 
Employment rate 42.3% 52.9% 
 
One way of exploring the link between illness and low labour-force participation 
is to compare how the ARV patients and the representative sample of 
Khayelitsha residents responded to a question asking how often health problems 
interfered with their ability to work or look for a job.  As can be seen from Table 
6, over half of the ARV patients reported in the base-line survey that health 
problems were affecting their ability to work at least some of the time.  By 
contrast, only a third of the Khayelitsha sample reported that health problems 






Table 6: Health Problems and Labour-Force Participation 
 
How often health problems affected ability to 





All the time 11.2% 1.2% 
Most of the time 20.2% 6.1% 
Some of the time 20.1% 26.4% 
None of the time 48.5% 66.3% 
 
Table 7 provides information on changes over time in reported health status for 
the 104 ARV patients for whom we have information at base line and after one 
year of treatment.  As can be seen, there were sharp levels of improvement:  
whereas only 51% of the sample reported in the base-line survey that health 
problems affected their ability to work or look for work ‘none of the time’, this 
percentage rose to 82.7% after a year.  The numbers reporting no sick days 
likewise increased significantly from 60.6% to 90.4%. 
 
In the base line study, 45 percent of ARV patients reported that at least one 
member of the household took time to care for them.  This does not appear to 
have had much impact on household income, because only seven respondents 
reported that the caregiver had forgone income-earning opportunities as a result.  
Only three people reported that a school pupil had missed school to look after 
them (one reported that one school day had been lost and two reported that two 
school days had been lost).  In other words, unemployed people rather than 
school children and the employed were picking up the burden of caring for 
people suffering from AIDS-related illness.     
 
 
Table 7: Health Problems for the 104 ARV patients who remained in the sample 
after 1 year of treatment 
 
 Start of the 
programme (base 
line) 
After one year 
of treatment 
How often health problems affected ability to 
work and look for work 
  
All the time 9.8% 0.0% 
Most of the time 17.7% 0.0% 
Some of the time 21.5% 17.3% 
None of the time 51.0% 82.7% 
   
Percentage reporting no days in which they were 





2.2 Reasons for Loss of Previous Job 
 
Of the 84 people who were not employed at the time the base line study was 
conducted, 80% (67 people) reported that they had worked before.  Table 8 
reports the reasons why these respondents lost the job.  Over half (55.3%) lost 
their jobs either as a result of illness or missing too many days of work.  Both of 
these reasons are likely to be HIV-related.  Interestingly, no one reported losing 
their job because their employer found out about their HIV-status.   The second 
largest reported reason for losing the previous job was retrenchment (29.9%).  
This is in line with data from the Khayelitsha sample indicating that 36.9% of 
those who were no longer employed, lost their previous jobs because they were 
retrenched.  Data such as this reflects the very difficult labour market situation 
existing for people in Khayelitsha.  
 
 











I lost my job due to illness 6 16 7 2 31+1* 47.8%
I missed too many days of work 0 3 2 0 5 7.5% 
I lost my job due to 
retrenchment/the company closed 
0 17 3 0 20 29.9%
The job was temporary 0 1 3 0 4 6.0% 
Other (non-HIV related) 0 3 2 1 6 9.0% 
Total 6 40 17 3 67 100% 





As reported in Table 4, fifty-three respondents in the base line study were 
classified as being employed.   Although most were in wage-employment, a 
smaller proportion of employed ARV patients were engaged in wage-
employment than was the case for the Khayelitsha sample.  Proportionately 
more of the ARV patients were engaged in self-employment and casual 
employment (although the cell sizes are too small for comfort).  
  
Of the 53 employed, only 44 gave valid responses for income.  As can be seen in 
Table 9, mean income for the wage-employed was R1400 per month (28 out of a 
possible 30 responses), for the self-employed: R728 per month (11/17 
responses) and for the casual employed: R706 (5/6 responses).   Average wage 
income is higher in the Khayelitsha sample (whether adjusted for inflation or 
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not) than for the ARV patients.   This could be because the average age of wage-




Table 9.  Mean Income from Employment 
 











































2.4 Household Income 
 
The study of ARV patients asked respondents in each survey whether household 
income had changed over the past six months.  Fifty-seven percent of 
respondents said in the base line study that it had stayed the same, and 35% 
reported that it had decreased (only 3% reported it had increased, and 5% said 
they did not know).   
 
Table 10 provides information on reported changes over time in this variable for 
the 104 respondents who remained in the sample after a year of treatment.  As 
can be seen, from the table, there was a significant difference between the way 
the question was answered at base-line, and after a year of treatment.  
Significantly more respondents reported that their household incomes had 
                                                 
4 However, the fact that the average school attainment of those ARV patients who were wage-
employed was Grade 10, as opposed to Grade 9 in the Khayelitsha sample would have acted as a 
counterweight to the age premium in the Khayelitsha sample.  Unfortunately the sample size for wage 
employed in the study of ARV patients is too small (n=28) to conduct meaningful earnings function 
analysis.  An earnings function estimated with three explanatory variables (gender, age and education) 
revealed that the signs were all in the expected direction (being male increased earnings, extra years of 
education increased earnings and extra years of age increased earnings) but none of the variables were 
significant. 
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increased, and significantly fewer reported that their household incomes had 
decreased.   
 
 
Table 10.  Reported change in monthly household Income for the 104 
respondents who remained in the sample after one year of treatment 
 
Has your monthly household income 
changed in the last six months?  
Start of treatment After one year of 
treatment 
I don’t know 6% 8.7% 
Yes, it has decreased 32% 22.1% 
Yes, it has increased 3% 19.2% 
No, it has stayed the same 59% 50.0% 
Total 100% 100% 
Pearson Chi2 = 15.0068 Pr= 0.002 
 
Of those respondents in the base line study who reported having lost their jobs in 
the previous year, 68% reported that their household incomes had decreased in 
the past six months.  This illustrates the importance of wage income to 
household income. 
 
Table 11 provides information on the sources of monthly household income for 
both samples.  Household income was calculated the same way in both data sets:  
income from employment was added to income from grants and income from 
other sources for all members of the household.5  However, it is worth noting 
three important methodological differences between the two surveys which 
affects comparability.  Firstly, in the Khayelitsha survey, each adult was 
interviewed – and their income data was added together to get a total income 
estimate for the household.  In the study of ARV patients, only one person was 
interviewed (the clinic attendee) and that person reported on the income for 
other household members.  Secondly, the survey of ARV patients only asked for 
two categories of income of other household members:  income from work, and 
income from grants (thus, we cannot differentiate between different types of 
employment income at the household level).  Thirdly, the study of ARV patients 
did not ask about remittances to the household other than to the individual 
respondent.  This is why ‘other’ income is such a relatively low proportion of 
total household income for the ARV patients compared to the Khayelitsha 
sample.    
 
 
                                                 
5 The Khayelitsha Mitchells Plain survey asked more detailed questions about income and hence a 
more sophisticated estimate of household income can be obtained from this survey (see Skordis and 
Welch, 2004).  Such a methodology was not used here because it would have limited the 
comparability between the two studies.  
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Table 11: Composition of Household Income 
 
Percentage of Household Income 
Contributed by: 




Wage income 38.0% 50.3% 
Income from casual employment  9.1% 
Income from self-employment  5.9% 
Grant income 60.8% 9.4% 
Other income* 1.2% 25.3% 
Total 100% 100% 
* These figures are not comparable because the ARV survey only asked the respondent about other 
income – other household members were only asked about employment income and grant income. The 
Khayelitsha/Mitchell’s Plain survey asked all household members about all forms of income. 
 
This almost certainly resulted in a downward bias to household income in the 
study of ARV patients.  If the ‘other’ income of other household members is 
excluded from the household income calculation for the Khayelitsha sample, 
then mean household monthly income drops from R1,606 to R1,518.  Taking 
these estimates as a guide, this suggests that monthly household income for 
ARV patients is probably underestimated by 5% as a result of the survey asking 
only about the employment and grant income of other household members.   
 
 
Table 12: Comparative Income Data (Khayelitsha and the Base Line ARV 
Survey) 
 










R1,463 R1,754 R1,606 
Household income 
minus disability grant 
income (mean) 




income to household 
income 
31.7% 1.5% 1.5% 
Average per capita 
household income 
R340 R458 R419 
Average household 
income for those 
households with a 
disability income 
R1,510 R1,497 R1,371 
Adjusted by the consumer price index which rose by 9.2% in 2002 (SARB Quarterly Bulletin, 
December 2003). 
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Table 12 presents information on household income.  It shows figures for the 
base line study of ARV patients in 2002 and for the Khayelitsha sample inflated 
upwards by 9.2% to adjust for consumer inflation between 2001 and 2002.  The 
adjusted figures must be treated with some caution because they assume that all 
incomes rose in line with consumer inflation – which was probably not the case 
for many people.  However, in order to make the data as comparable as possible 
with the data from the study of ARV patients, this adjustment was necessary 
because the two data sets were collected over a year apart.   
 
Two results stand out from Table 12.  Firstly, household income and per capita 
household income are similar between the ARV patients and the comparative 
Khayelitsha sample (adjusted to 2002 prices); although the latter data is 
consistently higher than the former.  Given that the household income of ARV 
patients is under-estimated by the failure of the survey to capture remittance 
income going to other household members, we can probably safely assume that 
average household income levels are for all intents and purposes the same 
between the two surveys.   However, the distribution of household income is 
much more unequal in the Khayelitsha survey.  This can be seen in Figure 1 




































Africans in Khayelitsha (20-59)
 
 
Figure 1.  Income Distribution in the ARV and Khayelitsha Samples 
 
The second striking feature of Table 12 is that the disability grant contributes far 
more towards household income for the ARV patients than is the case for the 
Khayelitsha sample.  This is to be expected because the ARV sample comprises 
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people with a serious illness – and because the MSF clinic helps ensure that 
most of the people they have on treatment also access the disability grant.  Thus, 
not only are more people likely to be eligible for the disability grant in the ARV 
sample compared to Khayelitsha, but they are also more likely to succeed in 
obtaining the grant if eligible.    
 
The disability grant is subject to various conditions – including a means test and 
a medical report confirming the disability.  Being unemployed is not a sufficient 
condition for obtaining a disability grant – the individual has to be too sick to 
work.   Seventy-three percent of the sample of ARV patients reported receiving 
a disability grant.  However, of these individuals, 22% reported that they were 
working.  Fifteen percent were classified as wage-earners (earning a mean 
monthly wage of R1,099), 2% were casual workers and 5% were self-employed.  
Ten percent of those receiving the disability grant were earning more than the 
value of the disability grant.   
 
Table 12 also indicates that the average standard of living is low in both 
samples.  An average household monthly per capita income of R340 (the ARV 
sample) is the equivalent of $1.6 per person per day (assuming an exchange rate 
of R7:$1).  Unsurprisingly, then, the largest expenditure item for the ARV 
sample is food (accounting for an average of 44.8% of total household 
expenditure).  This is followed by 12.7% on transport, 11.0% on savings, 10.1% 
on education, 9.1% on services (electricity and water) and 5.7% on health.   
 
The share of health expenditure may seem surprisingly low at first glance given 
that the households in the ARV sample comprise people starting their treatment 
programme.  They are thus in advanced stages of AIDS and hence are likely to 
be suffering from opportunistic infections.  However, as most of their health 
needs are being met by the Khayelitsha clinic, this almost certainly accounts for 
the low expenditure share.  HIV-related costs are probably being incurred in 
other ways, e.g. through higher transport costs (if the person is too sick to walk 
to the clinic).  Unfortunately the Khayelitsha survey did not ask questions about 
expenditure, so it is not possible to contextualise these expenditure patterns with 






This paper attempted to place the sample of ARV patients in a comparative 
context using data from the Khayelitsha Mitchell’s Plain survey.  Although 
differences in questionnaire design limits comparability in a number of cases, 
there are a few robust findings.  The strongest findings are (as one would 
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expect) that at base-line, the ARV patients suffered from a higher degree of 
reported ill-health and disability than did the Khayelitsha sample, and that 
labour-force participation rates were correspondingly lower for ARV patients.  
Preliminary analysis of the panel data for the 104 ARV patients who remained 
in the sample, reveals that reported disability and ill-health declined sharply 
after a year on treatment.   
 
This is consistent with parallel studies using the same group of respondents 
showing that clinical indicators and quality of life improved significantly during 
the first year of treatment (MSF et al 2003; Jelsma et al, 2003).  Findings such 
as these suggest strongly that the increase in labour-force participation and in 
health status over the period can be attributed in large part to the impact of ARV 
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The Centre for Social Science Research 
 
The CSSR is an umbrella organisation comprising five units:  
 
The Aids and Society Research Unit (ASRU) supports quantitative 
and qualitative research into the social and economic impact of 
the HIV pandemic in Southern Africa.  Focus areas include:  the 
economics of reducing mother to child transmission of HIV, the 
impact of HIV on firms and households; and psychological 
aspects of HIV infection and prevention.  ASRU operates an 
outreach programme in Khayelitsha (the Memory Box Project) 
which provides training and counselling for HIV positive people 
 
The Data First Resource Unit (‘Data First’) provides training and 
resources for research.  Its main functions are: 1) to provide 
access to digital data resources and specialised published 
material; 2) to facilitate the collection, exchange and use of data 
sets on a collaborative basis; 3) to provide basic and advanced 
training in data analysis; 4) the ongoing development of a web 
site to disseminate data and research output.    
 
The Democracy in Africa Research Unit (DARU) supports students 
and scholars who conduct systematic research in the following 
three areas:  1) public opinion and political culture in Africa and 
its role in democratisation and consolidation; 2) elections and 
voting in Africa; and 3) the impact of the HIV/AIDS pandemic on 
democratisation in Southern Africa. DARU has developed close 
working relationships with projects such as the Afrobarometer (a 
cross national survey of public opinion in fifteen African countries), 
the Comparative National Elections Project, and the Health 
Economics and AIDS Research Unit at the University of Natal. 
 
The Social Surveys Unit (SSU) promotes critical analysis of the 
methodology, ethics and results of South African social science 
research. One core activity is the Cape Area Panel Study of 
young adults in Cape Town.  This study follows 4800 young people 
as they move from school into the labour market and adulthood.  
The SSU is also planning a survey for 2004 on aspects of social 
capital, crime, and attitudes toward inequality. 
 
The Southern Africa Labour and Development Research Unit 
(SALDRU) was established in 1975 as part of the School of 
Economics and joined the CSSR in 2002.  SALDRU conducted the 
first national household survey in 1993 (the Project for Statistics on 
Living Standards and Development).  More recently, SALDRU ran 
the Langeberg Integrated Family survey (1999) and the 
Khayelitsha/Mitchell’s Plain Survey (2000).  Current projects 
include research on public works programmes, poverty and 
inequality.  
 
 
 
